Prof Harshal Nandurkar
Honorary Clinical Professor
Department of Medicine
88 Scholarly works
18 Projects
HIGHLIGHTS
2026
Journal article
A Multicenter, Double-Blind, Placebo-Controlled, Randomized Clinical Trial of Oral Anticoagulation in Systemic Sclerosis-Related Pulmonary Arterial Hypertension—Results From the SPHInX Study
DOI: 10.1002/pul2.703312025
Journal article
Global coagulation assays for patients with diabetes and their utility in the prediction of atherothrombotic events
DOI: 10.1016/j.bvth.2025.1000792025
Journal article
Tissue factor pathway inhibitor levels and atherothrombotic events in patients with chronic kidney disease or diabetes
DOI: 10.1007/s11239-025-03077-32025
Journal article
Endothelial -targeted CD39 is protective in a mouse model of global forebrain ischaemia
DOI: 10.1186/s12974-025-03394-72024
Journal article
Development of endothelial-targeted CD39 as a therapy for ischemic stroke
DOI: 10.1016/j.jtha.2024.04.0232023
Journal article
Current challenges in the prevention and management of post-thrombotic syndrome—towards improved prevention
DOI: 10.1007/s12185-023-03651-62023
Journal article
DOAC-stop can remove direct oral anticoagulants and allow analysis by global coagulation assays
DOI: 10.1111/ijlh.14020
RECENT SCHOLARLY WORKS
2023
Journal article
Global coagulation assays in patients with chronic kidney disease and their role in predicting thrombotic risk
DOI: 10.1016/j.thromres.2023.04.0162023
Journal article
N-Terminomic Changes in Neurons During Excitotoxicity Reveal Proteolytic Events Associated With Synaptic Dysfunctions and Potential Targets for Neuroprotection
DOI: 10.1016/j.mcpro.2023.1005432023
Journal article
Overall haemostatic potential (OHP) assay can risk stratify for venous thromboembolism recurrence in anticoagulated patients
DOI: 10.1007/s11239-022-02686-6
RECENT PROJECTS
2014
Research Grant
A Multi-Centre Double-Blind Randomised Placebo-Controlled Trial of Oral Anticoagulation in Systemic Sclerosis-Related Pulmonary Arterial Hypertension
2013
Research Grant
Targeting GRP-78 as a Means to Overcome Drug Resistance and as a Therapeutic Modaliaty Against Multiple Myeloma
2014
Research Grant
Targeting GRP-78 as a Means to Overcome Drug Resistance and as a Therapeutic Modaliaty Against Multiple Myeloma
2013
Internal Research Grant
Characterization of a Novel Regulator of Haemostasis
2011
Research Grant
Study of New Mechanisms That Control Blood Clotting